Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
10612studies shown
Showing 2,557-2,568 of 10,612
Drug study icon
CompletedNCT04447287

Safety study of buprenorphine/Naloxone in Addiction

This study is completed in the United States. It is testing buprenorphine/Naloxone for Addiction.

In United States
AddictionDrugA study involving a medication or substance.From 18 Years to 60 Years
Countries
United States
Sponsor
Astellas Pharma Global Development, Inc.
Condition
Addiction
Drug study icon
CompletedNCT07038876

ML-007C-MA for schizophrenia

This study is completed in the United States. It is testing ML-007C-MA for schizophrenia.

In United States
SchizophreniaDrugFrom 18 Years to 64 Years
Countries
United States
Sponsor
MapLight Therapeutics
Condition
Schizophrenia
Drug study icon
TerminatedNCT04855747

REL-1017 for depression

This study was terminated in the United States. It is testing REL-1017 for depression.

In United States
DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Levomecor Inc.
Condition
Depression
Drug study icon
CompletedNCT05972044

Solriamfetol for ADHD

This study is completed in the United States. It is testing solriamfetol for ADHD.

In United States
ADHDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Axsome Therapeutics, Inc.
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.